Safety and efficacy of PD-1 and PD-L1 inhibitors in relapsed and refractory Hodgkin's lymphoma: a systematic review and meta-analysis of 20 prospective studies.
Chenxi SunHuixian ChenYongjing WangChengyun ZhengPublished in: Hematology (Amsterdam, Netherlands) (2023)
PD-1/PD-L1 inhibitors show promising efficacy and tolerable AEs in the treatment of R/R HL.